Monday, December 3, 2018
Edwards Lifesciences receives clearance for HemoSphere platform
Edwards Lifesciences announced that the HemoSphere advanced hemodynamic monitoring platform has received U.S. FDA clearance for the Acumen suite of intelligent decision-support solutions.
https://thefly.com/landingPageNews.php?id=2831153
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.